Wellisch Alejandro D 4
4 · ABBOTT LABORATORIES · Filed Feb 22, 2023
Insider Transaction Report
Form 4
Wellisch Alejandro D
Senior Vice President
Transactions
- Award
Option (right to buy)
2023-02-17+31,236→ 31,236 totalExercise: $106.24From: 2024-02-17Exp: 2033-02-16→ Common Shares (31,236 underlying)
Footnotes (1)
- [F1]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 10,412 on February 17, 2024, 10,412 on February 17, 2025, and 10,412 on February 17, 2026.